Drugs / arbutin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00717652 | Jul 2008 | hyperpigmentation of the skin | Azidus Brasil | Suspended | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | arbutin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00717652 ↗ |
| Known as | Arbutinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL232202 ↗ |
| Known as | Arbutoside | ChEMBL registry synonym — accepted as the source's own label CHEMBL232202 ↗ |
| Known as | NSC-4036 | ChEMBL registry synonym — accepted as the source's own label CHEMBL232202 ↗ |
| Known as | Ursin | ChEMBL registry synonym — accepted as the source's own label CHEMBL232202 ↗ |
| Action | Inhibit | “Tyrosinase inhibitor” CHEMBL232202 ↗ |
| Modality | Small molecule | — CHEMBL232202 ↗ |
| Target | TYR | “Tyrosinase inhibitor” CHEMBL232202 ↗ |